MONOCLONAL ANTIBODIES AGAINST THE HUMAN ANTI-MÜLLERIAN HORMONE TYPE II RECEPTOR (AMHR-II)Teulon, IsabellePelegrin, André
替代品名称3 MIS RII(AMHR2,抗苗勒管激素受体,II型,AMHR,AMH II型受体,抗苗勒管激素2型受体前体,抗苗勒管激素II型受体,MISRII,MIS II型受体,MRII)(生物素) 替代品名称2 MIS RII(AMHR2,抗苗勒管激素受体,II型,AMHR,AMH II型受体,抗Muellerian激素2型受体前体,抗Muellerian激素II型受体,MISRII,MIS II...
人物简介: 何芬,曾担任西充县多扶镇卡伊妮干洗店等公司股东。 老板履历 图文概览商业履历 任职全景图 投资、任职的关联公司 商业关系图 一图看清商业版图 更新时间:2024-11-21关联企业0 担任法定代表人0 担任股东0 担任高管0 所有任职企业0 作为最终受益人0 所属集团0 历史信息2 曾担任法定代表人 曾担任...
AMHR-IIdoi:10.1007/3-540-29623-9_6119Anti-müllerian hormone Type II receptor. Receptor Serine/Threonine KinaseSpringer Berlin HeidelbergEncyclopedic Reference of Genomics & Proteomics in Molecular Medicine
The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers.トゥロン,イザベル...
The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers.TEULON, ISABELLE...
PROBLEM TO BE SOLVED: To provide monoclonal antibodies and fragment thereof specific to the human anti-mullerian hormone type II receptor (AMHR-II) for use in the treatment and diagnosis of cancer diseases such as ovarian cancer.SOLUTION: The monoclonal antibodies having specificity to the human ...
The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers.ISABELLE TEULON ET AL...
The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type Il receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers.doi:EP1918304 A1TEULON ISABELLE...
(b) a light chain whose variable domain comprises at least one CDR having a sequence selected from the group consisting of respective specific sequences related to CDR-1, CDR-2 and CDR-3, the monoclonal antibodies having specificity to human anti-mullerian hormone type II receptor (AMHR-II)....